Universal-Beteiligungs- und Servicegesellschaft
PTGX icon

Universal-Beteiligungs- und Servicegesellschaft’s Protagonist Therapeutics PTGX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Sell
102,002
-3,512
-3% -$367K 0.02% 572
2026
Q1 		$11.1M Sell
105,514
-8,522
-7% -$755K 0.02% 574
2025
Q4 		$9.96M Buy
114,036
+23,719
+26% +$1.94M 0.02% 615
2025
Q3 		$6M Buy
90,317
+49,833
+123% +$2.83M 0.01% 795
2025
Q2 		$2.24M Buy
40,484
+36,288
+865% +$1.74M ﹤0.01% 1189
2025
Q1 		$203K Buy
+4,196
New +$176K ﹤0.01% 1887

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's PTGX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Protagonist Therapeutics (PTGX) stake by 3.3% in Q2 2026, selling an estimated $367K and leaving 102,002 shares worth $12.5M. The position accounts for 0.02% of the portfolio, ranked #572.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in PTGX in Q1 2025 and has held it in 6 quarters since. 195 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 102,002 shares of Protagonist Therapeutics worth $12.5M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 3,512 Protagonist Therapeutics shares in Q2 2026, an estimated $367K.
  • Protagonist Therapeutics made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #572 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Protagonist Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 195 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.